See if you stop GHK-Cu what happens for what to expect after discontinuing
A large analysis published December 10 in Neurology , the medical journal of the American Academy of Neurology, found that people with type 2 diabetes who took GLP-1 medications were modestly less likely to develop epilepsy than those taking another common class of diabetes drugs
This leads to appetite suppression
Ozempic is clinically effective for weight management, and the 6-month trial period gives the body time to respond to semaglutide before escalating to tirzepatide
Clinical data from cardiovascular outcome trials suggests that semaglutide users experienced modest improvements in systolic blood pressure readings, independent of weight loss alone
Our study found that use of GLP-1 drugs, compared to DPP-4 inhibitors and other antidiabetic drugs, was associated with a meaningful reduction in cancer progression across four solid tumor types, said lead study author Mark David Orland, MD, of the Taussig Cancer Institute at Cleveland Clinic, in the release